Skip to content
GLP-1 Decoder

Wegovy FDA Approval History: Every Indication, Dose and Date

Wegovy fda: what happened, what it means for patients, and where to read the record.

Active ingredient
semaglutide
Manufacturer
Novo Nordisk
How it is taken
Weekly injection or daily pill
FDA-approved for
Weight loss, Heart risk, MASH liver disease

Key facts about Wegovy

<caption> How long it remains in your body
100%50%25%0%07 d14 d21 d28 d35 d50%25%12.5%time after the dose

Half-life: about 1 week. At 7 d, half is gone, and after five half-lives (35 d), about 3% remains.

<caption> Weight loss in its main trial
Wegovy (STEP 1)14.9%Placebo2.4%

In STEP 1 at 68 weeks, the results showed 14.9% for body weight, compared with 2.4% on placebo.

How the price changes over time
202520262027$1,349.02$0List priceSelf-pay

Monthly prices in US dollars cover list price and self-pay offers. The maker's price page provides each figure.

Sources: FDA label (DailyMed), healthsystemtracker.org, prnewswire.com 1 2.